Research
We have a bold ambition: to stop prostate cancer limiting men's lives. And it’s through funding research that we will make this happen.
TRANSFORM trial
Our research strategy
Research we fund
The impact of our research
Research webinars for supporters
Discover our 'From Ideas to Impact' webinar series - hear directly from our funded researchers, and men with lived experience of prostate cancer, from the comfort of your living room!
Latest news
New test could see better targeted treatment for men with advanced cancer – sparing thousands the side effects of chemotherapy
The test spots which men will get the most benefit from docetaxel chemotherapy – meaning those who are less likely to respond could avoid the drug’s side effects and instead receive other treatments that may help them more.
Diabetes treatment metformin could reduce treatment side effects for men with advanced prostate cancer
Men with advanced prostate cancer given metformin gained less weight, and had lower cholesterol and blood sugar levels, than men who didn't take the type 2 diabetes drug. More research is underway to see what other benefits the treatment could have.
Abiraterone can halve some men’s risk of dying – this AI test can work out who
An Al tool can predict which men with high-risk cancer will benefit from abiraterone. We call on the Government to make the treatment available to them, to reduce their risk of dying from the disease.
Our £2m trial to test whether this new scan could stop high-risk prostate cancer from spreading
The trial will test whether the new, more accurate scan can give men the targeted treatment they need to stop the spread of prostate cancer.
